Stay updated with breaking news from Nasdaq Lsta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Lisata Therapeutics (NASDAQ:LSTA – Free Report) in a report released on Thursday, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. Lisata Therapeutics Price Performance Shares of LSTA opened at $2.65 on Thursday. The firm has a market cap of $22.02 million, […]
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report)’s stock price shot up 9.3% during trading on Thursday . The stock traded as high as $2.70 and last traded at $2.70. 4,950 shares were traded during mid-day trading, a decline of 59% from the average session volume of 12,084 shares. The stock had previously closed at […]
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 59,700 shares, an increase of 497.0% from the December 15th total of 10,000 shares. Based on an average daily trading volume, of 19,900 […]
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 55,800 shares, an increase of 17.5% from the November 15th total of 47,500 shares. Approximately 0.8% of the shares of the stock are sold short. Based […]
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 54,600 shares, an increase of 10.5% from the October 15th total of 49,400 shares. Based on an average daily trading volume, of 21,300 […]